Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CIB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC152225 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101929607 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LAPTM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6785 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PMS2P9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
D21S2090E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
GIPC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AFF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD44-IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPRE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKNAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105374928 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01134 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on